According to Genscript Biotech
's latest financial reports the company has a price-to-book ratio of 1.50.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 2.59 | -47.7% |
2022-12-31 | 4.95 | -26.13% |
2021-12-31 | 6.70 | 168.06% |
2020-12-31 | 2.50 | -78.2% |
2019-12-31 | 11.5 | 128.54% |
2018-12-31 | 5.02 | -73.99% |
2017-12-31 | 19.3 | 345.69% |
2016-12-31 | 4.33 | 137.05% |
2015-12-31 | 1.83 |